Monday, February 24, 2020

Informa Connect – CBI’s 5th Annual IDN and Bio/Pharma Partnering Summit

Informa Connect – CBI’s 5th Annual IDN and Bio/Pharma Partnering Summit
April 1-3, 2020 | The Notary Hotel | Philadelphia, PA
www.cbinet.com/IDN

The 5th Annual IDN and Bio/Pharma Partnering Summit explores the partnership goals of both IDNs and manufacturers and provides a valuable opportunity to collaborate with established players in order to improve patient outcomes and population health, advance access, streamline efficiencies and improve compliance.

Exclusive Offer for Drug Channels Readers:
to SAVE $400* using promo code DRG400

This year's robust agenda features an unprecedented speaking faculty leading the dialogue including Blue Cross Blue Shield of Michigan, Pfizer, Vanderbilt University Medical Center, Sobi, WellCare Health Plans, University of Pennsylvania Health System, Shionogi, Atrium Health, Ambry Genetics, Fairview Health, Sunovion and many more.

2020 Program Highlights:
  • Two In-Depth Workshops
    • A. Specialty Pharmacy Integration
    • B. Contracting with Employers
  • Benefit from the Payer Perspective on the Current Landscape and Emerging Trends in Total Patient Care
  • Address Improving Population Health on a Broad Scope
  • Define and Develop Standards for Measuring Patient Outcomes
  • Hear Vanderbilt Address Adherence in Specialty Pharmacy
  • Learn how to Illustrate the Value of Working with IDNs to Executive Leadership
  • Engage with Industry Veterans and Hear Best Practices from IDNs and Manufacturers
  • Engage in Partnering Meetings to Collaborate with Stakeholders and Cultivate Relationships
Download the conference agenda for the complete speaker and session lineup, then register using promo code DRG400 to receive $400 off* the standard rate!

*Discount expires 3/31/2020; not valid on workshop only and cannot be combined or applied to existing registration. Other restrictions may apply.


The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.

No comments:

Post a Comment